Files in this Data Supplement:
Table S1 (Phase I clinical trial of AZD1208 patient dosing) and Fig. S1 (Pim kinase inhibitor and cell surface MET expression), S2 (Wound-healing/scratch assay), S3 (eIF4B regulates MET expression), S4 (Pim-1 phosphorylation of eIF4B), S5 (Pim and PI3K/AKT/mTOR pathways in phosphorylation of eIF4B), S6 (eIF4B S406 phosphorylation and MET translation), and S7 (Pim-1 and translation of INSR and c-Myc)
PDF, 4.0M